Keratoconus is the most common corneal ectatic disorder. It is characterized by progressive
corneal thinning with resultant irregular astigmatism and myopia. Its prevalence has been …

Since its inception in the late 1990s, corneal cross-linking has grown from an interesting
concept to a primary treatment for corneal ectatic disease worldwide. Using a combination of …

Background: Despite extensive knowledge regarding the diagnosis and management of
keratoconus and ectatic corneal diseases, many controversies still exist. For that reason …

Purpose To compare the results of standard corneal crosslinking (CXL) and transepithelial
iontophoresis‐assisted CXL after 24 months follow‐up. Material and methods Corneal …

Keratoconus is a disease characterized by progressive thinning, bulging, and distortion of
the cornea. Advanced cases usually present with loss of vision due to high irregular …

Purpose To compare the clinical effects and safety of transepithelial corneal cross-linking
(CXL) to epithelium-off (epi-off) CXL in progressive keratoconus. Design Randomized …

Since the late 1990s corneal crosslinking (CXL) has been proposed as a new possibility to
stop progression of keratoconus or secondary corneal ectasia, with the promising aim to …

PURPOSE: To assess the long-term efficacy and safety of epithelium-off corneal cross-
linking according to the Dresden protocol (S-CXL) in progressive keratoconus. METHODS …

Purpose To evaluate the in vitro efficacy of rose bengal–and riboflavin-mediated
photodynamic therapy for inhibition of methicillin-resistant Staphylococcus aureus (MRSA) …

Purpose: There has been a recent explosion in the variety of techniques used to accomplish
corneal cross-linking (CXL) for the treatment of ectatic corneal diseases. To understand the …